HIV News and Research

RSS

Studying the HIV response for pandemic preparedness

Researchers assessed the impact of utilizing the human immunodeficiency virus (HIV) response in improving pandemic preparedness.

27 Jan 2023

Montana pharmacists may get more power to prescribe

Mark Buck, a physician and pharmacist in Helena, Montana, said he's been seeing more patients turn to urgent care clinics when they run out of medication.

27 Jan 2023

Researchers discover the impact of microRNA on inflammation in lupus

A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupus in mice.

26 Jan 2023

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

According to the World Health Organization, each year there are an estimated 1 billion cases of influenza, between 3-5 million severe cases and up to 650,000 influenza-related respiratory deaths globally.

25 Jan 2023

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Researchers described the coronavirus disease 2019 (COVID-19) prevention network (CoVPN) and its contribution to clinical efficacy evaluations of COVID-19 vaccines in phase 3 trials.

25 Jan 2023

Understanding endemic and novel zoonotic spillovers from rodent trapping studies

The global impact of novel zoonotic pathogen spillovers has been highlighted through the ongoing coronavirus disease 2019 (COVID-19) pandemic caused by the rapid outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. In the past, similar effects were recorded during the HIV/AIDs and Spanish Influenza pandemics.

24 Jan 2023

A slight increase in Mpox cases across the globe, along with an increase in deaths

The WHO discusses genomic sequencing of the Mpox virus, in addition to providing public and clinical health links between HIV and Mpox.

24 Jan 2023

Researchers review the association between endogenous retrovirus reactivation and aging

Researchers explored the role of endogenous retrovirus (ERV) reactivation in the aging process.

24 Jan 2023

Review on lateral flow test use spearheaded by SARS-CoV-2 pandemic

Researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons learnt from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

23 Jan 2023

WHO’s 14th situation report for the multi-country outbreak of mpox overviews the clinical and public health links between HIV and mpox

In the present report, researchers reported the most recent findings of MPXV infections.

23 Jan 2023

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination.

22 Jan 2023

Intimate partner violence has far-reaching impacts in humanitarian settings

Intimate partner violence is pervasive in humanitarian settings and its impacts are far-reaching, finds a new study from the Brown School at Washington University in St. Louis.

20 Jan 2023

Wistar scientists receive $397,663 to explore the ability of natural killer cells to kill HIV-infected cells

amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years. Montaner, who leads The Wistar Institute's HIV Research Program, is studying the ability of a type of immune cell known as natural killer (NK) cells to kill HIV-infected cells.

19 Jan 2023

Exploring the infectivity, transmissibility, and immunological resistance characteristics of SARS-CoV-2 Omicron XBB.1.5 strain

Researchers performed an epidemic dynamic analysis to assess the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC)’s sub-VOC XBB.1.5 characteristics.

19 Jan 2023

HIV News and Research

Studying the HIV response for pandemic preparedness

Montana pharmacists may get more power to prescribe

Researchers discover the impact of microRNA on inflammation in lupus

Atomic-level computer model of the H1N1 virus reveals new vulnerabilities

Exploring the contribution of COVID-19 prevention network to SARS-CoV-2 vaccine efficacy clinical trials

Understanding endemic and novel zoonotic spillovers from rodent trapping studies

A slight increase in Mpox cases across the globe, along with an increase in deaths

Researchers review the association between endogenous retrovirus reactivation and aging

Review on lateral flow test use spearheaded by SARS-CoV-2 pandemic

WHO’s 14th situation report for the multi-country outbreak of mpox overviews the clinical and public health links between HIV and mpox

Phase I trial results from AdaptVac's COVID capsid virus-like particle vaccine

Intimate partner violence has far-reaching impacts in humanitarian settings

Wistar scientists receive $397,663 to explore the ability of natural killer cells to kill HIV-infected cells

Exploring the infectivity, transmissibility, and immunological resistance characteristics of SARS-CoV-2 Omicron XBB.1.5 strain

Investigational vaccine regimen safe but did not provide protection against HIV acquisition

Study sheds new light on how the B cell academy mounts a diverse immune response

Tight transmission bottlenecks may limit the evolution of SARS-CoV-2 variants

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

Scientists use paleogenomics to trace 10,000 years of human immune system evolution

Recent findings on original antigenic sin and SARS-CoV-2

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News